Abivax Reports Positive Phase 3 Results for Bowel Disease Drug but Some Patients Developed Cancer
Abivax said its experimental drug helped patients with chronic inflammatory bowel disease in a pivotal study. Some trial participants developed cancer that the company said was unrelated to treatment.
themarketherald.com.auAbivax said its experimental drug helped patients with a chronic inflammatory bowel disease in a crucial study. The French biotech company reported the findings from a late-stage clinical trial. The same trial recorded cases of cancer among some patients.
Abivax stated that those cancers were unrelated to the treatment. @business reported that the study results could prompt takeover offers for the company.
Transparency
Reported by a single outlet. This score reflects source tier and factual specificity — corroboration is limited with one source.
Story details
Related Stories
thehindu.comRubio Tells Congress Iran's Mojtaba Khamenei Is Alive and Increasingly Active as U.S. Seeks Concessions
Marco Rubio testified before Congress on Tuesday that Iran's Supreme Leader Mojtaba Khamenei is alive and increasingly engaged. He also restated U.S. commitment to reopening the Strait of Hormuz.
thenation.comHegseth Rejects Navy One-Star Promotions Selected by Board, Citing Merit Over DEI
Pete Hegseth removed several senior Navy officers from a promotion list to one-star admiral and four Army colonels from a brigadier general list. The moves follow earlier interventions and come after 19 senior generals or flag officers have been fired or sidelined since he took o…
France 24EU Agrees on Rules to Deport Rejected Migrants to Third-Country Return Hubs
European Union lawmakers and member states agreed Monday on new rules that let countries send migrants ordered to leave the bloc to centers in third countries. The deal creates a legal framework for return hubs where rejected asylum seekers or people without legal status can be h…